AMR activities and resources

2025


To beat AMR, strengthen health systems — not just research funding

The second edition of the Global Health Resilience campaign from Mediaplanet launched today and once again the ESCMID AMR Action Subcommittee was a proud partner discussing the importance of AMR. In this second article Holger Rohde and Chantal Morel focus on the need to bolster overall health systems over addressing individual issues. Reforms to our health systems is essential to create the systemic change needed to beat AMR on a global scale. 

Read more
 


Fighting against Antimicrobial Resistance: the key to bolstering global health resilience

The ESCMID AMR Action Subcommittee partnered with Mediaplanet on their Global Health Resilience campaign which launched on 30 April 2025. They bring in the important topic of fighting Antimicrobial Resistance to bolster global health resilience. You can read the full article covering the need for global collaboration and inclusion of policy changes to properly combat AMR.

Read more
 


ESCMID-GLG Science Policy Forum @ESCMID Global 2025 - Building the steps for policy implementation

At the 35th ESCMID Global Congress in Vienna, ESCMID and the AMR Global Leaders Group co-hosted the third joint Science Policy Forum to advance dialogue between scientists and policy-makers. This year’s Forum focused on the outcomes of the 2024 UNGA-AMR High-level Meeting, particularly the political commitments aimed at reducing the global burden of antimicrobial resistance (AMR). Key stakeholders from international organisations, academia, and national authorities gathered to discuss how to translate these commitments into evidence-based policy action.

Download report
 


WHO issues its first-ever reports on tests and treatments for fungal infections

Fungal infections are an increasing global health threat, disproportionately affecting vulnerable populations—including patients with cancer, HIV, organ transplants, or those in intensive care. Mortality rates remain unacceptably high, yet diagnostic tools are often unavailable, especially in low- and middle-income countries, and treatment options remain limited. Alarmingly, only three antifungal drugs are currently in late-stage clinical trials, and diagnostic capacity falls far short of what is needed for timely and appropriate care.

Despite steady increases in recent years, antifungal resistance still receives limited attention within the broader antimicrobial resistance (AMR) agenda. This gap may have significant consequences in terms of morbidity, mortality, length of hospital stay, healthcare costs, and adverse outcomes.

To address this, the World Health Organization (WHO) has just published its first-ever reports on antifungal diagnostics and therapeutics—a landmark step that highlights both the urgency of the threat and the historical neglect of fungal pathogens. The WHO calls for enhanced global surveillance, greater investment in research, and stronger cross-sector coordination—including in agriculture, where fungicide use may drive resistance to clinical antifungals.

For ESCMID members, these reports represent a clear call to action: we must push for fungal infections to be fully integrated into AMR strategies, support innovation, and promote collaboration among clinicians, microbiologists, and policymakers.

Let’s ensure fungal infections are no longer the “neglected dimension” of AMR.

Read more

Written by: Antonio Vena (EFISG Educational Officer), Jon Salmanton-García (EFISG Chair), Valentijn Schweitzer (ESCMID AMR Action Communications Officer), Holger Rohde (ESCMID AMR Action Director)
 


2024


Commentary on ESCMID's key takeaways from WAAW 2024

The AMR Action Subcommittee published a commentary with the support of the Trainee Association of ESCMID (TAE) covering their activities during World AMR Awareness Week 2024. This annual event is a major time to reflect on and bring to light the ongoing challenges of antimicrobial resistance. This year the theme was “Educate. Advocate. Act now.”  and the subcommittee organised a webinar series in collaboration with the TAE and ISID to discuss topics like epidemiology, surveillance and policy. You can read on their activities and the key takeaways from the events along with their ideas for the path forward in this commentary published in CMI Communications.

Read more
 


Joint AMR and Emerging Infection Subcommittee statement on hypervirulent Klebsiella pneumoniae

There is a concerning recent emergence of a hypervirulent Klebsiella pneumoniae exhibiting extensive or panresistant phenotype through acquisition of carbapenemase-encoding elements. Between the two ECDC risk assessments in March 2021 and February 2024 the number of EU/EEA countries reporting cases increased from 4 to 10, with the total number of reported cases increasing from 12 to 143. Despite control efforts, there is now evidence of sustained spread of a specific lineage of hypervirulent carbapenemase-producing K. pneumoniae, i.e. ST23-K1, in one European country (Ireland) as well as potential within-country transmission in three other European countries (France, Latvia, and Lithuania) although epidemiological data to confirm this were missing.  

Links


New report from the GLG on AMR

A new report from the Global Leaders Group (GLG) on AMR outlines 10 policy recommendations for consideration at the UN General Assembly High-level Meeting on AMR in September 2024.

Download

2025


World AMR Awareness Week 2025 Webinar Series

Complex Problems, Diverse Perspectives and Integrated Solutions: Rethinking AMR Response with our WAAW 2025 Webinar Series

Help us to learn more about our audience and fill our short survey

Go to survey
 


Part 1: Beyond the Frontlines: Tackling AMR in Conflict and Crisis Zones

This webinar will explore the humanitarian and geopolitical dimensions of antimicrobial resistance, highlighting challenges in surveillance, stewardship, diagnostics, and treatment in conflict settings. Speakers will share frontline experiences and research insights to discuss strategies for mitigating AMR in humanitarian crises.

28 October 2025, 16:00 – 17:30 CET

Moderator(s): Tuomas Aro

Speakers: Aula Abbara (Médecins Sans Frontières) & Guido Granata (National Institute for Infectious Diseases “L. Spallanzani”, Italy)

Register now
 


Part 2: Digital Tools and AI for Smarter Prescribing in Remote Areas

This webinar will focus on AI-supported prescribing platforms, digital diagnostics, and other tools, while addressing ethical considerations, equity, and implementation challenges. Speakers will highlight how these advances are transforming research approaches and clinical decision-making.

04 November 2025, 16:00 – 17:30 CET

Moderator(s): Holger Rohde, Claudio Neidhöfer, David Eyre

Speakers: Daniele Roberto Giacobbe (IRCCS Ospedale Policlinico San Martino, Italy) & Doaa Amin (University College Dublin)

Register now
 


Part 3: It’s Not Just Bugs – It’s Us! The Intersection of Behavioural Science and AMR 

This webinar will explore how behavioural nudges, framing, and habit loops can improve prescribing practices and public awareness. It will cover examples from primary care settings, strategic behavioural analyses and published AMR trials.

11 November 2025, 16:00 – 17:30 CET

Moderator(s): Tomislav Mestrovic, Filippo Medioli, Diane Ashiru-Oredope

Speakers: Aleksandra J. Borek (SWPS University, Poland) & Tim Chadborn (WHO)

Register now
 


Part 4: The Vaccine Dividend – How Immunization Can Be Used to Halt the Rising Burden of AMR

This webinar will highlight how vaccines can reduce antibiotic use and save lives, emphasizing vaccines currently in development with the highest potential impact on AMR. Attendees will gain insights into the role of vaccination in combating resistance and improving global health outcomes.

08 November 2025, 12:00 – 13:30 CET

Moderator(s): Anna Both, Christian Kraef

Speakers: Chinwe Iwu-Jaja (Vaccine Preventable Disease Programme, World Health Organisation) & Nimesh Poudyal (AMR Department, International Vaccine Institute)

Register now
 


2024


World AMR Awareness Week 2024 Webinar Series

Part 1: Epidemiology and Burden of Antimicrobial Resistance

Understanding the epidemiology and burden of antimicrobial resistance (AMR) is crucial for formulating effective public health strategies. This session will delve into the trends, regional variations and future projections of AMR – highlighting the importance of comprehensive data and targeted interventions.

28 October 2024, 17:00 - 18:00 CET

Moderators: Anna Both, Christian Kraef

  • AMR Time Trend and Future Health Scenarios of AMR Burden
    Mohsen Naghavi (University of Washington and Institute for Health Metrics and Evaluation, United States)
  • Regional Insights and Data Needs in AMR Burden Estimation
    Gisela Robles Aguilar (Oxford University, United Kingdom)

Watch the Replay
 


Part 2: Diagnostic Approaches and AMR Surveillance

Accurate and timely diagnosis is a cornerstone in the fight against AMR. This session will explore the challenges and innovations in diagnostic tools, especially in resource-limited settings, but also the importance of surveillance. It will also address global initiatives aimed at reducing diagnostic inequalities to improve AMR management worldwide.

6 November 2024, 17:00 - 18:00 CET

Moderators: Sara Tomczyk, Claudio Neidhöfer

  • Surveillance of Antimicrobial Resistance in the ECOWAS Region: Establishing the Foundation for Essential Interventions and Tackling Disparities in Diagnostics
    Ahmed Aboushady (Harvard Medical School, Boston, United States)
  • Resistance Surveillance and the Diversity of European Techniques
    Iva Butić (University of Zagreb, Croatia)

Watch the Replay
 


Part 3: Antibiotics Development / AWARE

The development of new antibiotics and the optimisation of existing treatments are vital to counter the growing threat of AMR. This session will cover the latest strategies in antibiotic development, the challenges faced in different phases of drug development, and the efforts to improve diagnosis and treatment of antibiotic-resistant infections.

13 November 2024, 15:30 - 16:30 CET

Moderators: Tomislav Mestrovic, Giorgia Caruana

  • The Rise of Bacterial G-Quadruplexes in Current Antimicrobial Discovery
    Mattia Mori (University of Siena, Italy; Chair of the European Network for diagnosis and treatment of antibiotic-resistant bacterial infections – EURESTOP)
  • Comprehensive Phases of Antimicrobial Drug Development: From Discovery to Market
    Stephen Hawser (IHMA Europe Sàrl, Switzerland)

Watch the Replay
 


Part 4: Global Strategy

This session will be in collaboration with the International Society for Infectious Diseases (ISID)

Global collaboration and policy-making are essential to effectively combat AMR. This session will discuss the strategic directions from the policy-makers, the specific needs of low- and lower-middle-income countries (LMICs), as well as the potential role of vaccines in reducing AMR. The focus will be on actionable policies and collaborative efforts to address this global health challenge.

20 November 2024, 17:00 - 18:30 CET

Moderators: Holger Rohde, Nicholas Power

  • Global and Regional AMR Policy in a Current Landscape: Strategic Directions and The Opportunities for Implementation
    Jameela Mohammed Al-Salman (Chair of the WHO Strategic Technical Advisory Group on AMR / Arabian Gulf University, Bahrain)
  • Assessing the needs of implementing AMR policies in LMICs
    Sujith J Chandy(Executive Director, ICARS, Denmark)
  • Equity Perspectives of AMR Policy and Practice
    Connie Walyaro (ISID / Talk AB[M]R / WHO Expert Working Group on Equity and AMR, Kenya)

Watch the Replay
 


2023


World AMR Awareness Week 2023

Day 1: evolutionary perspective on AMR emergence and control

Moderators: Holger Rohde, Giorgia Caruana

  • Lessons from environmental microbiology on the evolution of AMR
    Joakim Larsson, Sweden
  • Putting evolution into context: Role of human gut microbiota in AMR spread
    Willem van Schaik, United Kingdom
  • It’s all out there!? Mining for new approaches to combat AMR: Anti-resistance strategies, phages, and predators
    Paul Turner, United States

Watch the Replay
 


Day 2: controlling the emergence of AMR: Is technology the saviour?

Moderators: Anna Both, Claudio Neidhöfer

  • Faster, broader, more accurate: Prospects of next generation microbiology for AMR control
    Adrian Egli, Switzerland
  • Staying one step ahead: How artificial intelligence can be a game changer in AMR control
    Roy Kishony, Israel
  • The fast car is not enough: Integrative approaches to AMR control
    Bojana Beovic, Slovenia

Watch the Replay